• SELECT SITE CURRENCY
Select a currency for use throughout the site
Cancer Treatment Drugs Markets in China (12 Full Research Reports Collection)
AMID Co, May 2012, Pages: 2438
China's demand for cancer treatment drugs markets has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This is a collection of 12 full market research reports on lung cancer, breast cancer, prostate cancer, leukemia, ovrian cancer, colon cancer, cevical cancer, brain cancer, bladder cancer, liver cancer, kidney cancer, and skin cancer treatment drugs. These new studies examine China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers in China are profiled.
Pharmacia & Upjohn (Suzhou) Pharmaceutical Co., Ltd.
Yangtze River Pharmaceutical Group Co., Ltd.
Lianyungang Zhengda Pharmaceutical Co., Ltd.
Jiangsu Nanjing Pharmaceutical Factory
AstraZeneca (China) Pharmaceutical Co., Ltd.
Jiangsu Lianyugang Pharmaceutical Factory
Changzhou Qianhong Bio-pharma Co., ltd.
Changzhou Tianhua Pharmaceutical Co., Ltd
Changchun Lierfan Pharmaceutical Co., Ltd.
Jinzhou Jiutai Pharmaceutical Co., Ltd.
Dalian Jingang Pharmaceutical Co., Ltd.
Shenyang Shuangding Pharmaceutical Co., Ltd.
Shanghai Hongqi Pharmaceutical Co., Ltd.
Qilin Kunpeng (China) Biology Pharmacy Co., Ltd.
A sample for this product is available. Please Login/Register to download this sample.